New AAP Guidance: Exome and genome sequencing recommended as first-line tests. Learn more

Important Information Regarding GeneDx Test Menu Changes 

GeneDx has made the decision to exit the hereditary cancer testing space, allowing us to focus on exome and genome testing—areas where we believe we can have the greatest impact on patient care.

At the end of September, the hereditary cancer panels listed below will be removed from the GeneDx test catalog:

Test codeTest name
713FH Gene Sequencing & Del/Dup
714FLCN Gene Sequencing and Del/Dup
961Comprehensive NF Panel
B273Breast/Gyn Cancer Panel
B274Colorectal Cancer Panel
B275Comprehensive Common Cancer Panel
B343Pancreatic Cancer Panel
B362BRCA1/2 Sequencing and Del/Dup Analysis
B363Rest of Comprehensive Common Cancer Panel
B363aRest of Comprehensive Common Cancer Panel (after Breast/Gyn Cancer Panel)
B363bRest of Comprehensive Cancer Panel (after Colorectal Panel)
B363dRest of Comprehensive Cancer Panel (after Pancreatic Panel)
B363fRest of Comprehensive Cancer Panel (after Lynch/Colon Panel)
B394Renal Cancer Panel
B522Lynch/Colorectal High-Risk Panel
B749OncoGeneDx Custom Panel
B749ACustom Panel
B751Common Cancer Management Panel
B752Rest of Comprehensive Common Cancer Panel (after Common Cancer Management Panel)
J006MSH2 Exons 1-7 Inversion Analysis
J054Rest of Comprehensive Common Cancer Panel (after Breast Cancer Management Panel)
J055Breast Cancer Management Panel
J664Rest of Comprehensive Cancer Panel (after Prostate Panel)
J665Hereditary Prostate Cancer Panel
J832Rest of Comprehensive Cancer Panel (after BRCA1/2)
J939Rest of Comprehensive Cancer Panel (after RCC Panel)
J947Reflex FLCN Sequencing and Deletion/Duplication
T830Hereditary MDS/Leukemia Panel
TB53SJLIFE Pediatric Cancer Survivorship Panel
TB54Hereditary Cancer Mosaic Variant Test
TK88xG Tempus
TM18xG+ (extended hereditary cancers)
J810KPSC Hereditary Cancer Panel
J827Rest of Cancer Panel (after KPSC Hereditary Cancer)

To view the complete list of available test options, visit the GeneDx test menu

Important dates for hereditary cancer testing:

September 16, 2025

  • Last day to place an order via the portal

September 30, 2025

  • Last day that samples will be accepted (portal or TRF orders)
  • Last day to place an order via paper test requisition form (TRF) (accompanied by the sample)

If you place an order for these tests through an EMR, please contact your EMR provider to update your ordering system.

Questions? We’re happy to help. Please contact our client services team (US and Canada) at 888-729-1206 or Support@GeneDx.com. If you are outside the US or Canada reach us at 301-519-2100 or International@GeneDx.com.